ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 3647

$1.2M Total Retail Price of All Prescriptions

Rank: 140 out of 3647

929 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 929 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 929 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,525 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,388 972 1 3
LEVOTHYROXINE SODIUM 1,192 951 2 5
HYDROCODONE-ACETAMINOPHEN 963 592 S3 3 12
LISINOPRIL 820 588 4 4
LOVASTATIN 815 609 5 21
FUROSEMIDE 656 507 6 8
METOPROLOL TARTRATE 628 473 7 7
AMLODIPINE BESYLATE 619 468 8 2
SIMVASTATIN 562 443 9 1
ALENDRONATE SODIUM 523 483 10 23
POTASSIUM CHLORIDE 498 392 11 24
MELOXICAM 434 359 12 33
METFORMIN HCL 429 334 13 6
GABAPENTIN 422 288 14 17
PRAVASTATIN SODIUM 407 252 15 16
BACLOFEN 406 230 16 97
HYDROCHLOROTHIAZIDE 394 307 17 9
SERTRALINE HCL 389 226 18 27
TRAZODONE HCL 344 196 19 64
ATENOLOL 329 274 20 10
WARFARIN SODIUM 326 293 21 15
FAMOTIDINE 322 250 22 61
CITALOPRAM HBR 318 218 23 25
DONEPEZIL HCL 260 253 24 30
GLIMEPIRIDE 246 186 25 45
PREDNISONE 244 170 26 43
GLYBURIDE 243 184 R 27 54
CIPROFLOXACIN HCL 230 177 28 53
ZOLPIDEM TARTRATE 229 125 29 14
TRAMADOL HCL 210 128 30 22
MIRTAZAPINE 208 188 31 63
ALPRAZOLAM 207 152 32 31
PLAVIX 191 142 33 39
NAMENDA 184 184 34 49
ALLOPURINOL 174 113 35 37
MUPIROCIN 171 125 36 137
CLOPIDOGREL 171 123 36 26
PAROXETINE HCL 169 117 38 60
DIGOXIN 166 118 39 51
CARVEDILOL 163 98 40 20
OXYBUTYNIN CHLORIDE 162 108 41 107
DOXYCYCLINE HYCLATE 157 101 42 145
ESCITALOPRAM OXALATE 156 135 43 65
PROAIR HFA 152 79 44 62
LORATADINE 149 120 45 109
ACARBOSE 148 102 46 437
GEMFIBROZIL 144 102 47 82
VENTOLIN HFA 139 70 48 88
ATORVASTATIN CALCIUM 134 95 49 13
ISOSORBIDE MONONITRATE ER 132 103 50 56
AZITHROMYCIN 129 78 51 34
TRIAMTERENE-HCTZ 126 104 52 58
RISPERIDONE 123 93 53 83
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 76 54 36
METOCLOPRAMIDE HCL 118 76 55 135
IBUPROFEN 117 54 56 55
NOVOLOG 116 67 57 123
METOPROLOL SUCCINATE 116 81 57 18
LEVOFLOXACIN 115 97 59 87
KLOR-CON M20 114 92 60 121
SINGULAIR 113 74 61 90
FLUTICASONE PROPIONATE 112 61 62 32
QUETIAPINE FUMARATE 112 75 62 89
LOSARTAN POTASSIUM 112 90 62 11
INSULIN SYRINGE 112 48 62 76
DOXAZOSIN MESYLATE 109 76 66 57
CYCLOBENZAPRINE HCL 108 24 R 67 98
IPRATROPIUM-ALBUTEROL 108 107 67 150
LEVETIRACETAM 104 69 69 122
NOVOLIN 70-30 102 54 70 130
PANTOPRAZOLE SODIUM 101 69 71 38
NEXIUM 99 67 72 44
POLYETHYLENE GLYCOL 3350 98 66 73 143
CRESTOR 97 50 74 19
TERAZOSIN HCL 97 76 74 103
TEMAZEPAM 91 85 76 47
LEXAPRO 91 83 76 177
CLONIDINE HCL 90 50 78 46
FLUOXETINE HCL 89 66 79 68
HUMULIN 70-30 88 71 80 192
MECLIZINE HCL 87 64 81 85
SPIRONOLACTONE 86 66 82 77
ADVAIR DISKUS 85 60 83 52
NAPROXEN 85 39 83 70
DIVALPROEX SODIUM 82 75 85 131
PHENYTOIN SODIUM EXTENDED 82 44 85 199
TAMSULOSIN HCL 80 69 87 28
AMITRIPTYLINE HCL 79 32 R 88 105
NYSTATIN 79 67 88 195
OXYCODONE-ACETAMINOPHEN 79 36 S2 88 91
LIDODERM 78 65 91 108
RANITIDINE HCL 76 57 92 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 57 93 110
NOVOLIN R 73 62 94 139
CYMBALTA 71 47 95 79
EXELON 70 70 96 129
LEVEMIR 69 38 97 187
AMOXICILLIN 68 36 98 133
PRANDIN 67 48 99 348
OXYCODONE HCL-ACETAMINOPHEN 66 46 S2 100 104
FINASTERIDE 65 57 101 66
GLIPIZIDE 65 41 101 41
ENALAPRIL MALEATE 65 62 101 35
LANTUS 64 53 104 59
LORAZEPAM 63 46 105 73
TOPIRAMATE 62 12 106 254
MONTELUKAST SODIUM 61 35 107 160
ACYCLOVIR 59 35 108 259
DICLOFENAC SODIUM 56 26 109 86
DIAZEPAM 56 32 109 214
ABILIFY 55 46 111 205
KLOR-CON M10 55 55 111 227
KETOCONAZOLE 55 34 111 132
ZETIA 54 26 114 96
BENAZEPRIL HCL 53 46 115 71
RAMIPRIL 52 0 116 101
FLUCONAZOLE 51 32 117 226
DILTIAZEM ER 51 34 117 167
DOXYCYCLINE MONOHYDRATE 51 29 117 559
METRONIDAZOLE 51 36 117 247
DILTIAZEM 24HR ER 50 31 121 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.